Current Cancer Therapy Reviews


Yangchao Chen
School of Biomedical Sciences
Faculty of Medicine
The Chinese University of Hong Kong
(Hong Kong)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 4 Issue: 1, February

Recent Advances in T Cell Adoptive Immunotherapy of Cancer

Volume:4   Issue: 1
Pp: 1-13
Li Zhang and Pouneh Dokouhaki
DOI: 10.2174/157339408783565475
Published on: 01 March, 2012

Apoptosis Signaling Pathways in Anticancer Therapy

Volume:4   Issue: 1
Pp: 14-20
Simone Fulda and Klaus-Michael Debatin
DOI: 10.2174/157339408783565510
Published on: 01 March, 2012

The Role of Nucleoside Transport in the Antineoplastic Activity of Purine Nucleoside Chemotherapeutic Agents

Volume:4   Issue: 1
Pp: 21-30
Carol E. Cass and Karen M. King
DOI: 10.2174/157339408783565501
Published on: 01 March, 2012

Membrane Tyrosine Kinase Receptors are an Important Target for the Therapy of Acute Myeloid Leukemia

Volume:4   Issue: 1
Pp: 31-49
Ugo Testa
DOI: 10.2174/157339408783565466
Published on: 01 March, 2012

Cancer Therapeutics: Emerging Targets and Trends

Volume:4   Issue: 1
Pp: 50-56
Mohd. Fahad Ullah
DOI: 10.2174/157339408783565493
Published on: 01 March, 2012

HER2 in the Era of Molecular Medicine: A Review

Volume:4   Issue: 1
Pp: 57-65
Karen A. Callaghan, Rachel E. Ellsworth, Darrell L. Ellsworth and Craig D. Shriver
DOI: 10.2174/157339408783565529
Published on: 01 March, 2012

Molecular Replacement in Cancer Therapy: Reversing Cancer Metabolic and Mitochondrial Dysfunction, Fatigue and the Adverse Effects of Cancer Therapy

Volume:4   Issue: 1
Pp: 66-76
Garth L. Nicolson and Kenneth A. Conklin
DOI: 10.2174/157339408783565484
Published on: 01 March, 2012